PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
20-Jun-2024 Sound Bioventures expands portfolio with new investment in US company NephroDI Therapeutics to accelerate development of NDI-5001 for pediatric orphan kidney disease Sound Bioventures
20-Jun-2024 Sanofi to appeal after disappointment with NICE’s Final Draft Guidance not recommending isatuximab (SARCLISA ) suggesting this standard-of-care treatment in multiple myeloma is not cost-effective even if it had been offered at no cost Sanofi
20-Jun-2024 NEW TESTS TO IDENTIFY HEREDITARY CANCER RISKS TO BE LAUNCHED edx medical
20-Jun-2024 Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience Clinion Inc
19-Jun-2024 Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development Macomics and the Institute of Oncology Research
19-Jun-2024 Lundbeck broadens focus on neurohormonal dysfunctions with new Cushing’s disease trial Lundbeck
19-Jun-2024 Kenvue Publishes Largest Set of Clinical Data on Anti-Aging Gold Standard: Retinol Kenvue
18-Jun-2024 Accelerating Drug Discovery with the CCDC, AWS, and Intel: Curated Data Set of Protein Structures from the Protein Data Bank with Predicted Hydrogen Positions Now Available Amazon Web Services (AWS) and Intel, the CCDC
18-Jun-2024 Beckman Coulter Life Sciences Revolutionizes High-Throughput Genomic Sample Preparation with the New Biomek Echo One System Beckman Coulter Life Sciences
18-Jun-2024 Scientists develop new treatment for pain associated with sciatica and migraines Neurolieve Biosciences
18-Jun-2024 Research shows potential ‘life-transforming’ mole reversal therapy in rare condition Francis Crick Institute
17-Jun-2024 CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations CluePoints
17-Jun-2024 EHA 2024: Systemic mastocytosis (SM) patients in Europe face up to five years to obtain a diagnosis Blueprint Medicines
17-Jun-2024 NEW DATA PRESENTED AT EHA 2024 SHOW THE POTENTIAL OF CALQUENCE (ACALABRUTINIB) COMBINATION THERAPY TO PROVIDE DURABLE AND PROLONGED PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA AstraZeneca
17-Jun-2024 HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology HUTCHMED
17-Jun-2024 TALVEY®▼ (talquetamab) demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma Johnson & Johnson
17-Jun-2024 Updated Phase 2 CAPTIVATE study results demonstrate sustained clinical benefit of fixed-duration IMBRUVICA® (ibrutinib) plus venetoclax as first-line treatment for patients with chronic lymphocytic leukaemia, including those with high-risk disease Johnson & Johnson
14-Jun-2024 NEW KITE CLINICAL RESEARCH AND REAL-WORLD EVIDENCE FOR YESCARTA® (AXICABTAGENE CILOLEUCEL) DEMONSTRATE BENEFIT FROM EARLIER LINES OF TREATMENT KITE
14-Jun-2024 Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024 Celltrion
13-Jun-2024 Resolution Therapeutics to Host Virtual R&D Webinar on Liver Disease with World Leading Hepatologist Arun Sanyal, M.D. Resolution Therapeutics